Conventional transarterial chemoembolisation in combination with sorafenib for patients with hepatocellular carcinoma: a pilot study
about
Advanced hepatocellular carcinoma and sorafenib: Diagnosis, indications, clinical and radiological follow-upManagement of hepatocellular carcinoma with portal vein thrombosisCombination trans arterial chemoembolization (TACE) plus sorafenib for the management of unresectable hepatocellular carcinoma: a systematic review of the literature.Efficacy of sorafenib monotherapy versus sorafenib-based loco-regional treatments in advanced hepatocellular carcinoma.A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 "multi-points priming" mechanisms in vitro and in vivInefficiencies and Patient Burdens in the Development of the Targeted Cancer Drug Sorafenib: A Systematic ReviewSorafenib in advanced hepatocellular carcinoma: current status and future perspectives.Clinical trials in hepatocellular carcinoma: an update.Molecular targeting agents associated with transarterial chemoembolization or radiofrequency ablation in hepatocarcinoma treatment.Consensus recommendations and review by an International Expert Panel on Interventions in Hepatocellular Carcinoma (EPOIHCC).Combination of local transcatheter arterial chemoembolization and systemic anti-angiogenic therapy for unresectable hepatocellular carcinoma.Antiangiogenic treatment in hepatocellular carcinoma: the balance of efficacy and safety.Doxorubicin -eluting beads in the treatment of liver carcinoma.Re-evaluating transarterial chemoembolization for the treatment of hepatocellular carcinoma: Consensus recommendations and review by an International Expert Panel.Combination therapy of sorafenib and TACE for unresectable HCC: a systematic review and meta-analysis.Transarterial chemoembolization and sorafenib in hepatocellular carcinoma.Interventional Oncology in Hepatocellular Carcinoma: Progress Through Innovation.Comparative effectiveness of traditional chemoembolization with or without sorafenib for hepatocellular carcinoma.Trends in utilization of transarterial treatments for hepatocellular carcinoma: results of a survey by the Italian Society of Interventional Radiology.Efficacy of combination treatment modalities for intermediate and advanced hepatocellular carcinoma: intra-arterial therapies, sorafenib and novel small molecules.Magnetic resonance-imaging of the effect of targeted antiangiogenic gene delivery in a melanoma tumour model.Early sorafenib induction after transarterial chemoembolization for unresectable hepatocellular carcinoma: Can sorafenib after TACE improve loco-regional control?The combination of transcatheter arterial chemoembolization and sorafenib is well tolerated and effective in Asian patients with hepatocellular carcinoma: final results of the START trial.Safety assessment of sorafenib in Chinese patients with unresectable hepatocellular carcinoma: subgroup analysis of the GIDEON study.Letter: sorafenib in portal hypertension - authors' replyTransarterial chemoembolization plus sorafenib for the management of unresectable hepatocellular carcinoma: a systematic review and meta-analysis
P2860
Q26851033-0AC8CD4B-C67B-41AE-B83B-AC3517EB731EQ26996578-6A4ADD19-C65D-40BE-B90F-46B0ABF471D5Q34991643-7796B73D-2D66-42DF-A573-5BAE6374133CQ35025403-97E44E6A-33FA-4295-A20A-29649789DE41Q35695946-3D6AACD1-EDE8-4E93-AC62-D2D581881637Q36270115-0BFF0785-A240-4F9D-9D0F-162D92612259Q37031712-9EAF4F73-1D14-4009-98E3-88E643429794Q37435638-50361E25-2508-4538-B5B6-40245BC1C02DQ37581359-AAD926A7-BF5C-46EC-B2A5-02C9BAF350E7Q38075142-7FEB5A8A-08BE-4709-A27D-BF5C1D9A4BFFQ38155510-6ED16253-D002-4269-B6D6-81015E1E5945Q38160838-83A7E9EF-25D4-4854-BCED-2E9F54692774Q38161583-43A0CBA6-9182-44AF-A038-902AA415330BQ38164112-64EE646B-65AA-4026-AB82-0113840062B3Q38197831-5E433817-15C9-4DF7-8238-D1402A005682Q38213650-FA32D932-A234-46A1-A656-089053A41A7AQ38792625-D11771BF-80BB-434B-9D11-74EF5B676465Q39375746-302E1DB6-E106-4FC5-81EC-5CE38524CD20Q39410889-624C35FB-0517-4B3E-AD04-355B4AC89BD1Q40389227-493F8CA6-37F0-4A41-9575-55E8DED3F72AQ45870579-F183FAD6-B4BB-4CA7-AC2B-22A34E24041BQ47160017-39FC8F24-1A41-4B88-BE92-DDC5D639EE59Q48238287-B3D3E8F1-A84E-4C9D-99CF-CF14D431EB88Q52676764-B1FAA355-6656-49FD-9DEB-0A269EB9D8FEQ57168147-B269881C-89E8-4533-AA3D-AD6FF2F0B747Q58765170-691C6CF2-6D7C-4B2C-9733-750CE2ED0BD7
P2860
Conventional transarterial chemoembolisation in combination with sorafenib for patients with hepatocellular carcinoma: a pilot study
description
im Januar 2012 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 04 January 2012
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 2012
@uk
name
Conventional transarterial che ...... lular carcinoma: a pilot study
@en
Conventional transarterial che ...... lular carcinoma: a pilot study
@nl
type
label
Conventional transarterial che ...... lular carcinoma: a pilot study
@en
Conventional transarterial che ...... lular carcinoma: a pilot study
@nl
prefLabel
Conventional transarterial che ...... lular carcinoma: a pilot study
@en
Conventional transarterial che ...... lular carcinoma: a pilot study
@nl
P2093
P2860
P1433
P1476
Conventional transarterial che ...... lular carcinoma: a pilot study
@en
P2093
Ahmed Ba-Ssalamah
Christian Müller
Johannes Lammer
Matthias Pinter
Michael Reisegger
Wolfgang Sieghart
P2860
P2888
P304
P356
10.1007/S00330-011-2368-Z
P407
P577
2012-01-04T00:00:00Z